ArticleInvestigational new drugs2019

Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma.

Lei Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.